Good Medicine Podcast
Every year, promising therapies fail in clinical trials. But failure doesn't always mean the drug didn't work. In this episode of the Good Medicine Podcast, Dr. David Bearss and Dr. Jeremiah Bearss explain how clinical trials work, why so many therapies never make it to patients, and the complexity behind bringing a new medicine to market. They discuss the different reasons a clinical trial may fail, why meeting a clinical endpoint doesn't always lead to FDA approval, and how commercial viability plays a major role in determining whether a therapy ultimately reaches patients. The conversation also explores how artificial intelligence may transform drug development by identifying biological patterns and therapeutic targets that humans would struggle to find on their own. Topics covered include: • Why drugs fail clinical trials• The challenges of FDA approval and commercialization• How AI could improve the future of drug development 🎧 Listen on Spotify and Apple Podcasts📺 Subscribe for more conversations on science, medicine, and innovation. Thank you to our sponsorsBioHive: https://www.biohive.com [https://www.biohive.com]Galvan: https://galvan.sng.link/D4mh8/oe8k/litt [https://galvan.sng.link/D4mh8/oe8k/litt] Follow Good Medicine PodcastInsta: https://www.instagram.com/good.medicine.podcast/ [https://www.instagram.com/good.medicine.podcast/]X: https://x.com/GoodMedicinePod [https://x.com/GoodMedicinePod]TikTok: https://www.tiktok.com/@good.medicine.podcast [https://www.tiktok.com/@good.medicine.podcast]LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/ [https://www.linkedin.com/company/goodmedicinepodcast/]
64 episoder
Kommentarer
0Vær den første til at kommentere
Tilmeld dig nu og bliv en del af Good Medicine Podcast-fællesskabet!